L.1. Risk factors and risk assessment tools

Table 36. Studies excluded from the clinical review

L.2. Diagnostic tests

Table 37. Studies excluded from the clinical review

Table 38. Studies identified by the GDG which were picked up in the search but excluded from the clinical review during the first sift, prior to ordering full papers

L.3. Severity risk tools

Table 39. Studies excluded from the clinical review

L.4. Surveillance for the early detection of hepatocellular carcinoma (HCC)

Table 40. Studies excluded from the clinical review

L.5. Surveillance for the detection of varices

Table 41. Studies excluded from the clinical review

L.6. Prophylaxis of variceal haemorrhage

Table 42. Studies excluded from the clinical review

L.7. Primary prevention of bacterial infections in cirrhosis and upper gastrointestinal bleeding

Table 43. Studies excluded from the clinical review

L.8. Transjugular intrahepatic portosystemic shunt (TIPS) versus large-volume paracentesis (LVP) for ascites

Table 44. Studies excluded from the clinical review

L.9. Primary prevention of spontaneous bacterial peritonitis (SBP) in people with cirrhosis and ascites

Table 45. Studies excluded from the clinical review

L.10. Volume replacers in hepatorenal syndrome

Table 46. Studies excluded from the clinical review

L.11. Management of an episode of acute hepatic encephalopathy

Table 47. Studies excluded from the clinical review